WASHINGTON — The chair and ranking Republican on the Senate Finance Committee on Thursday unveiled a bipartisan list of overarching reforms to drug middlemen’s business practices that they would like to pursue.
A legislative package of mostly drug pricing policies is coming together in the Senate, and these policies were not expected to be part of it, four drug lobbyists said. It seems to be an effort by Finance Chair Ron Wyden (D-Ore.) to play catch-up, in an effort to be included in the package that Senate Majority Leader Chuck Schumer is pulling together.
“He has talked to me about these issues,” Wyden said Tuesday when asked whether he expects Schumer to include the Finance Committee proposals. “All of the committees are going to work together.”
Create a display name to comment
This name will appear with your comment